Free training and education courses and webinars are available for health practitioners using depot buprenorphine to treat patients with opioid dependence.
This page will be updated with more training and education resources as they become available.
Treatment of Opioid Dependence with Depot Buprenorphine
This course is designed to support prescribers and other health professionals in providing depot buprenorphine treatment in a safe and effective manner in line with the NSW Opioid Treatment Program (OTP).
Treatment of opioid dependency with depot buprenorphine products - Buvidal® and Sublocade®
Part 1 and Part 2 of the webinar are available on NSW Health's Youtube channel.
This webinar aims to explain the clinical guidance, evidence base, pharmacology, and risks associated with depot buprenorphine, and how to implement it as an Opioid Agonist Treatment for opioid dependency. We will discuss skills to help you identify suitable patients for depot buprenorphine and have conversations about the risks and benefits, and how to comply with the regulatory requirements of prescribing and storing of depot buprenorphine. The webinar was presented by Assoc Professor Nicholas Lintzeris, Director of Drug and Alcohol at South Eastern Sydney Local Health District on 16 June 2020
Introduction to Depot Buprenorphine in the Treatment of Opioid Dependent Patients.
This webinar, presented by Assoc Professor Nick Lintzeris and Dr Hester Wilson, explains the clinical guidance, evidence base, pharmacology, and risks associated with depot buprenorphine, and how to implement it as an Opioid Agonist Treatment (OAT) for opioid dependency.